Product peptide-cancer-research-peptides

Home > products > peptide> cancer-research-peptides

Catalog	name	Description	price
R-R-0896	Heterophyllin B	Heterophyllin B/CAS No.145459-19-4 is an active cyclic peptide isolated from Pseudostellaria heterophylla. Heterophyllin B provides a novel strategy for the treatment of esophageal cancer.	price>
R-R-0961	Histrelin acetate	Histrelin acetate/CAS No.220810-26-4, a GnRH analogue, is a GnRH Receptor agonist. Histrelin acetate increases serum luteinising hormone (LH), follicle stimulating hormone (FSH) and testosterone levels. Histrelin acetate can be used in the research of prostate cancer, endometriosis.	price>
R-R-1006	Kisspeptin-10, human TFA	Kisspeptin-10, human TFA is a potent vasoconstrictor and inhibitor of angiogenesis. Kisspeptin-10, human TFA acts as a tumor metastasis suppressor via its receptor GPR54. Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development. Kisspeptin-10/GPR54 signaling induces osteoblast differentiation via NFATc4-mediated BMP2 expression.	price>
R-R-1029	Selenocystine	Selenocystine/CAS No.2897-21-4 is a broad-spectrum anti-cancer agent. Selenocystine induces DNA damage in HepG2 cells, particularly in the form of DNA double strand breaks (DSBs). Selenocystine exhibits great promise as a therapeutic or adjuvant agent targeting DNA repair for cancer treatment.	price>
R-M-151	MART-1 (27-35) (human) trifluoroacetate salt,CAS :156251-11-5	MART-1 (27-35) (human) trifluoroacetate salt(CAS :156251-11-5) is a kind of cancer research peptides.We can also provide drug peptides, antibacterial peptides,cell permeability peptides and other peptide products.We can also provide customized products.	price>
R-M-169	H-Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val-OH trifluoroacetate salt,CAS : 168650-46-2	H-Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val-OH trifluoroacetate salt,CAS:168650-46-2 belongs to cancer research peptides.Natural peptide target of a CTL clone that recognizes the tyrosinase gene product on melanoma cells. The sequence YMDGTMSQV results from posttranslational conversion of Asn to Asp.Tyrosinase 369-377, human, a HLA-A2.1 restricted epitope peptide derived from tyrosinase, has been used to develop tumor targeted vaccines with mixed efficacy.	price>
R-M-170	H-Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val-OH trifluoroacetate salt,CAS :181477-43-0	Modified sequence of the gp100 epitope gp(209-217) ITDQVPFSV, in which a methionine replaced the natural threonine at position 2, bound to the HLA-A2 molecule with greater affinity than the unmodified peptide and was shown to have an increased ability to generate melanoma-reactive cytotoxic T lymphocytes (CTLs) in vitro when used for sensitization of peripheral blood mononuclear cells. IMDQVPFSV hold promise for the development of novel cancer immunotherapies.	price>
R-M-171	Ovalbumin (257-264) (chicken) trifluoroacetate salt,CAS :138831-86-4	SIINFEKL, an ovalbumin-derived peptide, is known to arise from natural processing of ovalbumin H-2b mouse cells. Cytotoxic T lymphocytes (CTL) from the ovalbumin-hsp70-immunized mice and a highly effective CTL clone (4G3) raised against ovalbumin-expressing EL4 tumor cells (EG7-OVA) were equally effective in terms of the concentration of this compound required for half-maximal lysis in a CTL assay.	price>
R-M-514	Ac-a-benzyl-muramyl-Ala-D-Glu(Lys(trans-(3-nitrocinnamoyl))-NH₂)-NH₂	MDP-C has been synthesized as a non-specific immunomodulator. MDP-C induces strong cytolytic activity by macrophages on P388 leukemia cells and cytotoxic activity by cytotoxic T lymphcytes (CTLs) on P815 mastocytoma cells.	price>
R-M-328	Angiopep-2 (TFFYGGSRGKRNNFKTEEYC)	Angiopp-2 (tffyggsrnkrnnfkteeyc) is a peptide, which can be used for glioma targeted therapy.	price>

...